骨壊死は、患部への血液供給不足によって引き起こされる骨死です。股関節と肩関節に最も多く見られますが、膝、肘、手首、足首など他の大きな関節にも起こる可能性があります。骨壊死は、病気や、骨折や脱臼などの重度の外傷により、骨への血液供給に影響を与えることで起こります。初期には症状がありません。対症療法が可能です。
目次
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Osteonecrosis - Overview
Osteonecrosis - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Osteonecrosis - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Osteonecrosis - Companies Involved in Therapeutics Development
Ankasa Regenerative Therapeutics Inc
CEFO Co Ltd
Enzo Biochem Inc
HysensBio Corp
ImmuneCyte Inc
Regenerative Arthritis & Bone Medicine Inc
Xcelia
Osteonecrosis - Drug Profiles
ART-1001 - Drug Profile
Product Description
Mechanism Of Action
ART-352L - Drug Profile
Product Description
Mechanism Of Action
CFM-801 - Drug Profile
Product Description
Mechanism Of Action
CFM-802 - Drug Profile
Product Description
Mechanism Of Action
CFM-803 - Drug Profile
Product Description
Mechanism Of Action
HB-601 - Drug Profile
Product Description
Mechanism Of Action
IMC-2015 - Drug Profile
Product Description
Mechanism Of Action
Osteonecrosis of jaws - Drug Profile
Product Description
Mechanism Of Action
RAB-001 - Drug Profile
Product Description
Mechanism Of Action
Stem Cell Therapy for Osteonecrosis - Drug Profile
Product Description
Mechanism Of Action
Osteonecrosis - Dormant Projects
Osteonecrosis - Discontinued Products
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Osteonecrosis, 2022
Number of Products under Development by Companies, 2022
Products under Development by Companies, 2022
Number of Products by Stage and Target, 2022
Number of Products by Stage and Mechanism of Action, 2022
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Osteonecrosis - Pipeline by Ankasa Regenerative Therapeutics Inc, 2022
Osteonecrosis - Pipeline by CEFO Co Ltd , 2022
Osteonecrosis - Pipeline by Enzo Biochem Inc, 2022
Osteonecrosis - Pipeline by HysensBio Corp, 2022
Osteonecrosis - Pipeline by ImmuneCyte Inc, 2022
Osteonecrosis - Pipeline by Regenerative Arthritis & Bone Medicine Inc, 2022
Osteonecrosis - Pipeline by Xcelia, 2022
Osteonecrosis - Dormant Projects, 2022
Osteonecrosis - Discontinued Products, 2022
List of Figures
Number of Products under Development for Osteonecrosis, 2022
Number of Products under Development by Companies, 2022
Number of Products by Top 10 Targets, 2022
Number of Products by Stage and Top 10 Targets, 2022
Number of Products by Top 10 Mechanism of Actions, 2022
Number of Products by Stage and Top 10 Mechanism of Actions, 2022
Number of Products by Top 10 Routes of Administration, 2022
Number of Products by Stage and Top 10 Routes of Administration, 2022
Number of Products by Top 10 Molecule Types, 2022
Number of Products by Stage and Top 10 Molecule Types, 2022
